Ray Dalio Alnylam Pharmaceuticals Inc

Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$262

Avg closing price
Price range
Ray Dalio Portfolio Stock Details (ALNY)

14 Ray Dalio Alnylam Pharmaceuticals Trades

The first Alnylam Pharmaceuticals trade was made in Q2 2021. Since then Ray Dalio bought shares seven more times and sold shares on six occasions. The investor sold all their shares in Q1 2025 and doesn't own any shares in Alnylam Pharmaceuticals anymore.

Avg closing price
Price range
Sold -6.45 Thousand shares Q1 2025
Avg closing price $256.56
Price range $233.07 - $290.70
Increased shares by 222.3% (+4.45 Thousand shares) Q4 2024
Avg closing price $262.40
Price range $232.27 - $300.55
New holding (+2 Thousand shares) Q3 2024
Avg closing price $260.22
Price range $233.81 - $287.01
Sold -1.95 Thousand shares Q1 2024
Avg closing price $166.82
Price range $146.51 - $198.20
Increased shares by 3.4% (+65 shares) Q4 2023
Avg closing price $170.34
Price range $151.41 - $196.57
Increased shares by 5.0% (+90 shares) Q3 2023
Avg closing price $190.79
Price range $170.77 - $211.65
Increased shares by 43.1% (+541 shares) Q2 2023
Avg closing price $198.26
Price range $185.01 - $212.05
New holding (+1.26 Thousand shares) Q1 2023
Avg closing price $210.20
Price range $182.66 - $235.53
Sold -1.28 Thousand shares Q4 2022
Avg closing price $213.29
Price range $185.11 - $241.31
Sold 15.1% shares (-229 shares) Q3 2022
Avg closing price $190.40
Price range $138.54 - $233.85
New holding (+1.51 Thousand shares) Q2 2022
Avg closing price $141.87
Price range $120.42 - $169.29
Sold -2.23 Thousand shares Q4 2021
Avg closing price $185.86
Price range $159.56 - $209.29
Sold 63.4% shares (-3.87 Thousand shares) Q3 2021
Avg closing price $187.58
Price range $169.75 - $207.73
New holding (+6.1 Thousand shares) Q2 2021
Avg closing price $146.46
Price range $128.63 - $176.89
Never miss a trade

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!

To improve your user experience we use cookies.